Acme United (ACU) Q2 2026: Gross Margin Expands 160 bps on MyMedic Mix, Tariff Relief Ahead
Acme United’s second quarter marked a pivotal shift as the MyMedic acquisition and easing tariff headwinds drove record gross margins, while volume-led growth returned to core lines. With healthcare now making up 70% of revenue and automation investments scaling, the company signaled a multi-quarter runway for margin and profit improvement. Management’s focus on operational leverage and retail channel expansion for MyMedic sets up a structurally stronger earnings base by year-end.
Summary
- Margin Expansion Outpaces Cost Pressures: MyMedic’s high-margin mix and fading tariff drag set up further profit gains.
- Volume Recovery in Core Businesses: Westcott and first aid lines returned to growth, reversing last year’s retail softness.
- Operational Leverage in Focus: Automation and channel expansion initiatives target sustained margin improvement into Q4 and beyond.
Business Overview
Acme United is a branded supplier of cutting tools, first aid, and medical products, generating revenue across retail, industrial, and direct-to-consumer (DTC) channels. Its business is anchored by Westcott, cutting tools and school supplies, and a broad healthcare portfolio now including MyMedic, a DTC-first aid kit provider. The company’s revenue mix is roughly 70% healthcare and 30% cutting tools, with operations in the US, Canada, and Europe.
Performance Analysis
Second quarter results reflected a significant step-change in both top-line growth and margin structure. Net sales rose double digits, with the MyMedic acquisition contributing incremental DTC revenue and a favorable gross margin mix. Excluding MyMedic, organic growth was robust, particularly in US first aid and Westcott cutting tools, both of which benefited from the resumption of retailer promotions and improved consumer demand. Europe posted standout gains, driven by new product lines and record profitability despite macro inflation.
Gross margin expanded 160 basis points to a record level, primarily due to the high-margin profile of MyMedic, although this was partially offset by lingering tariff-related inventory costs. SG&A as a percentage of sales increased, reflecting MyMedic’s heavier advertising spend, but management expects leverage as DTC efficiency improves and retail distribution scales. Free cash flow generation remained strong, even after funding the MyMedic acquisition and ongoing automation investments in manufacturing.
- Mix-Driven Margin Gains: MyMedic’s gross margins are structurally higher than legacy segments, but require elevated marketing investment for DTC growth.
- Volume Recovery Outpaces Price: Westcott’s 8% growth was volume-led, confirming retailer restocking and promotional activity have returned.
- Regional Divergence: Europe outperformed with 19% sales growth, while Canada lagged, with strength in first aid offset by sluggish cutting tool demand.
Inventory levels remain elevated as a buffer against supply chain and geopolitical risk, but management sees this as temporary, with working capital expected to normalize as tariff-impacted inventory clears.
Executive Commentary
"Our core businesses performed well in the second quarter. In the United States, net sales of first aid and medical products increased 10%, with growth in particular at mass market retailers. Other strong contributors in the quarter were the safety-made promotional first aid business, MedNap antiseptic wipes, and Spill Magic cleanup products. Also in the United States, the Westcott Cutting Tools business increased 8% during the second quarter."
Walter C. Johnsen, Chairman and CEO
"The gross margin as a percentage of sales increase for both periods was mostly due to the favorable mix from Higher Margin Direct-to-Consumer Mimetic Products. The higher percentage of sales was due to the higher amount of advertising needed for the direct-to-consumer MiMedic business."
Paul Driscoll, Chief Financial Officer
Strategic Positioning
1. MyMedic Integration and Channel Expansion
The MyMedic acquisition is transforming Acme’s margin profile, with management targeting retail channel expansion to supplement DTC sales. Cost synergies are being realized through consolidated sourcing, freight, and overhead elimination. The fourth quarter is expected to be seasonally strongest for MyMedic, with retail placements and operational leverage as key profit drivers.
2. Automation and Plant Upgrades
Major investments in automation at the new Spill Magic facility and regulatory upgrades at MedNap are intended to unlock capacity and access new markets, such as US hospitals. These moves aim to structurally lower unit costs and support long-term growth across the healthcare portfolio.
3. Core Business Resilience and Innovation
Westcott’s rebound is being driven by product innovation and restored retailer promotions, with titanium-coated cutting tools maintaining category leadership. The company’s first aid business is differentiated through marketing, product design, and global sourcing scale, supporting wins at major retailers and industrial distributors.
4. Geographic Diversification
European operations delivered record results despite macro headwinds, providing a hedge against US consumer volatility. Canada remains a small but stable contributor, with first aid outpacing softer cutting tool demand.
5. Technology-Enabled Growth
Smart Compliance software, an IoT-driven replenishment system for industrial first aid kits, is entering pilot distribution and could unlock incremental recurring revenue and customer stickiness if scaled successfully.
Key Considerations
This quarter’s results reflect a business in the midst of a strategic inflection, balancing margin-enhancing acquisitions with investments in automation and technology to drive future growth.
Key Considerations:
- Margin Mix Shift: MyMedic’s contribution is structurally positive for gross margins, but DTC advertising costs will require scaling retail channels to realize full profit potential.
- Tariff Relief Tailwind: As high-tariff inventory works through the system, core gross margins should expand further, supporting higher operating income.
- Volume-Led Recovery: Westcott’s growth was primarily unit-driven, signaling end-market demand normalization and improved retailer confidence.
- Operational Leverage in Focus: Automation and facility upgrades are designed to drive fixed cost absorption and support higher throughput in key growth segments.
Risks
Inflation, rising freight and fuel costs, and currency headwinds remain persistent risks, particularly for imported goods. While tariff headwinds are easing, any reversal or new regulatory action could pressure margins again. The DTC model for MyMedic is highly reliant on advertising effectiveness and consumer discretionary spending, introducing volatility if demand softens unexpectedly. Execution risk exists in scaling new retail channels and integrating acquisitions without margin dilution.
Forward Outlook
For Q3 2026, Acme United expects:
- Continued sales growth in first aid and medical products
- Further gross margin improvement as tariff-laden inventory sells through
- Strengthening profitability at MyMedic, with retail expansion in focus
For full-year 2026, management maintained its constructive outlook, highlighting:
- Gross margin expansion as high-cost inventory clears
- Operational leverage from automation and facility investments
- Strong fourth quarter expected for MyMedic due to holiday and FSA-driven seasonality
Management emphasized the multi-quarter nature of margin recovery and the importance of cost discipline and execution in channel expansion.
- Ongoing automation and plant upgrades will impact fixed costs but are expected to drive future margin expansion
- Retail channel wins for MyMedic and Smart Compliance pilots could materially impact 2027 run-rate
Takeaways
Acme United’s Q2 results validate its pivot toward a higher-margin, healthcare-centric portfolio, with MyMedic and automation investments setting the stage for multi-year profit improvement.
- Margin Structure Reset: MyMedic’s mix and tariff relief are expanding gross margin, offsetting inflation and SG&A drag from DTC scaling.
- Volume and Innovation Drive Core Growth: Westcott’s rebound and first aid momentum demonstrate that core segments remain resilient and responsive to end-market recovery.
- Execution on Channel and Tech Initiatives: The pace of retail distribution wins for MyMedic and Smart Compliance adoption will determine the slope of future earnings growth.
Conclusion
Acme United’s second quarter marked a clear inflection in profitability and strategic positioning. With margin tailwinds, operational leverage, and robust core demand, the company is poised to deliver structurally higher earnings as integration and automation programs gain traction.
Industry Read-Through
Acme United’s results highlight several sector-wide dynamics: First, the value of DTC healthcare acquisitions for margin expansion, but with the caveat that scaling retail and industrial channels is critical for sustainable profit. Second, automation and plant upgrades are becoming essential levers for operational resilience and cost control in light of persistent inflation and supply chain risk. Third, tariff volatility remains a material variable for global consumer and industrial goods, with inventory management and sourcing sophistication as key differentiators. Peers in tools, first aid, and consumer healthcare should note the accelerating shift toward higher-margin, branded portfolios and the strategic use of technology for recurring revenue and customer retention.